x
- Home
- About Diabetes
- Services
- Diabetes Mellitus Modeling Solutions
- R&D Services for Diabetes Mellitus and Diabetic Complications
- By Drug Development Process
- About Us
- Careers
- Contact Us
Diabetes is a chronic metabolic disease characterized by high blood sugar and is difficult to cure and generally requires lifelong medication. Disease models can be used as suitable research tools for diabetes. Ace Therapeutics can provide modeling services of T2DM to accelerate customer research progress.
Type 2 diabetes mellitus (T2DM) accounts for about 90% of all diabetic patients, and T2DM is mainly linked to insulin resistance. Obese individuals contain more adipose tissues, relating to the higher secretion of hormones and other substances that may increase the fluctuation of insulin sensitivity.
Interactions between the Environment, Epigenome, and Obesity and T2DM (Charlotte, L. and Tina, R. Cell Metabolism. 2019)
T2DM is more common in older adults, but a significant increase in the prevalence of obesity among children has led to more cases of T2DM in younger people. Even with currently available therapies, such as insulin injections, oral hypoglycemic agents, etc.
Principle of STZ Destruction of Pancreatic Islet β-Cells (Wu, J. and Yan, L. J. Diabetes, Metabolic Syndrome and Obesity. 2015)
T2DM is characterized by insulin resistance and the inability of the beta cell to sufficiently compensate. Therefore, animal models of T2DM tend to include models of insulin resistance and/or models of β-cell failure.
| Model | Description |
|---|---|
| Ob/ob Mouse Model | The model is homozygous for a mutation in leptin and develop obesity, hyperphagia, glucose intolerance, insulin resistance and transient hyperglycemia. |
| Db/db Mouse Model | The model is monogenic, insulin-resistant model, and due to a spontaneous mutation in the leptin receptor. |
| KK-Ay Mouse Model | KK-Ay mice develop impaired glucose tolerance and insulin resistance, and fasting hyperglycemia. |
| DIO Mice | The models develop severe obesity, increased glucose intolerance, moderate insulin resistance and elevated glucose levels. |
| NZO Mouse | NZO mouse is a polygenic model of obesity, created by selective breeding. |
| ZDF Rat | These rats are less obese but have more severe insulin resistance, which due to increased apoptosis levels in the beta cells. |
| OLETF Rat | The rat is derived from a spontaneously diabetic rat. |
| TallyHo Mouse | It is a naturally occurring model of obesity and T2DM derived from selective breeding of mice. |
The construction of diabetes models can better simulate the development of human diabetes. Ace Therapeutics providing modeling service which can be customized by customer needs. Our services include but not limited to the followings.
Highly Customizable
One-stop Services
High Quality
Professional Team
Ace Therapeutics offers cost-effect and high-quality research services for our clients worldwide. In addition, we offer a variety of mouse models and cell lines for diabetes research. Please feel free to contact us.
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.
